Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report Publisher



Amirkhani N1 ; Khalaji A1, 2 ; Alehossein P1, 3 ; Safaei M4 ; Aletaha N5 ; Miroliaee A5
Authors

Source: JGH Open Published:2023


Abstract

Glatiramer acetate (GA) is a widely used immune-modulating drug in relapsing multiple sclerosis (MS). Although a few cases of drug-induced liver injury during GA therapy have been reported earlier, herein we present the case of a 43-year-old woman with relapsing MS who experienced acute liver failure after GA therapy, ultimately leading to liver transplant. © 2023 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Other Related Docs
16. Is Monkeypox a Concern in Multiple Sclerosis Patients? a Letter to Editor, Archives of Academic Emergency Medicine (2022)